HMGB1 and systemic lupus erythematosus: To further confirm the effect of HMGB1 on the progression of SLE, we inhibited the function of HMGB1 in vivo by injecting BALB/c mice intramuscularly with glycyrrhizin which has been demonstrated to be the blocker of HMGB1 [41–43].